Mani Shankar Aiyar calls Modi ‘neech’; suspended from Congress

Agencies
December 8, 2017

New Delhi/Surat, Dec 8: Congress suspended Mani Shankar Aiyar on Thursday after the former Union minister stoked yet another acrimonious row by describing Prime Minister Narendra Modi as a "neech aadmi".

Aiyar's choice of words not only drew a ferocious attack from Modi in Surat but riled his own party functionaries who feared potential damage to its electoral prospects due to the diplomat-turned-politician's foot-in-the-mouth penchant. "He (Modi) is neech kism ka aadmi who has no sabhyata (civility)," Aiyar had said earlier in the day after Modi accused Congress of using Dalit icon B R Ambedkar merely to get votes and trying to erase his contribution in building India.

Addressing an election rally in Surat, Modi hit back at Aiyar and said dejected Congress functionaries had lost their mental balance and crossed all limits of decency. "Mani Shankar Aiyar has called me neech and from nichli jaati (lower caste). Is this not an insult to Gujarat? Is it not an insult to India's great values? But people of Gujarat will take revenge on December 18 and teach you the precise meaning of neech," Modi said.

The PM said Aiyar's remarks smacked of Congress's "Mughal mindset" that discriminated between the lower and upper castes. "I, as chief minister of Gujarat for 14 years and now as PM, have done nothing that has forced citizens to hang their heads in shame. If Congress feels that working for the poor and distressed is something too low, I can only wish them good luck," he said amid chants of "Modi Modi".

The PM even recalled Congress chief Sonia Gandhi's 10-year-old "maut ka saudagar" remark against him as he accused the rival of constantly insulting and conspiring against him. "Despite so many insults, I have not been vindictive as PM and BJP will always work to uphold the values of public life," he said.

With a procession of BJP functionaries alleging that Aiyar's controversial remark was a reflection of the Nehru-Gandhi family's arrogance and their sense of entitlement, and fear growing that the indiscretion might hurt the party in Gujarat, Congress led by Rahul Gandhi went into damage control. The party vice-president took to Twitter to disapprove of Aiyar's remark and asked him to apologise. "BJP and PM routinely use filthy language to attack the Congress party. The Congress has a different culture and heritage. I do not appreciate the tone and language used by Mani Shankar Aiyar to address the PM. Both the Congress and I expect him to apologise for what he said," Rahul said.

Though Aiyar can stubbornly hold his ground, he promptly obliged and blamed the derogatory remark on his poor Hindi. "My Hindi is not very good. Yes, I called Modi 'neech' but did not mean it as a low-born; I meant it as low," he said, recalling that his poor grasp of Hindi had failed him earlier too when he called former PM Atal Bihari Vajpayee a "nalayak" PM.

However, this did not fully assuage the worry of the potential fallout of Aiyar's slur against the PM in a state where in 2007, Sonia calling Modi "maut ka saudagar" had badly boomeranged on her party. Coming just after the controversy over Kapil Sibal for allegedly seeking to delay resolution of the Ayodhya dispute by seeking postponement of hearing in the SC until after the 2019 Lok Sabha elections, many in the party expressed concern over "self-goals" during the last lap of the Gujarat polls. Former Delhi CM Sheila Dikshit, in fact, suspected an effort to sabotage Rahul when he is about to take over as party president.

Comments

FairMan
 - 
Friday, 8 Dec 2017

All Congees are tomorrows BjP / RSS

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 20,2020

New Delhi, Apr 20: With 1,553 more COVID-19 cases, India's total number of coronavirus cases has reached 17,265, the Ministry of Health and Family Welfare said on Monday.

Out of the total cases, 14,175 cases are active, while 2,547 people have been cured/discharged/migrated and 543 deaths have been reported, as per the ministry.

As many as 36 deaths have been reported in the last 24 hours.

According to the Ministry of Health and Family Welfare, Maharashtra continues to be the worst-affected state with a total of 4,203 cases. While 507 patients have recovered, 223 deaths have been reported.

Delhi comes next with 2,003 cases, out of which 72 patients have recovered while 45 patients have died.

Rajasthan has confirmed 1,478 cases, out of which 183 people have recovered while 14 patients are dead.

Tamil Nadu has reported 1,477 cases, out of which 411 have recovered and 15 have succumbed to the virus.

Madhya Pradesh has reported 1,407 cases, including 127 patients recovered and 70 patients dead. On the other hand, Uttar Pradesh has 1,084 COVID-19 positive cases.

In Kerala, which reported the country's first COVID-19 case, 402 people have been detected positive for coronavirus.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com news network
May 6,2020

Mangaluru, May 6: Three more coronavirus positive cases have been reported in Dakshina Kannada district. 

According to fresh bulletin of health and family welfare department, an 11-year-old girl and a 36-year-old woman from Boloor in Mangaluru and a 16-year-old girl from Bantwal tested positive for the covid-19. 

All of them are undergoing treatment at Wenlock Hospital. Their condition is said to be stable. 

With this the total number of cases in the district reached 28 including 22 residents of Dakshina Kannada, 4 from Kasaragod, 1 from Udupi and 1 from Uttara Kannada.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.